Arrangement of Collecting Venules for the Endoscopic Diagnosis of Helicobacter Pylori
MOTIVATION
1 other identifier
observational
1,000
3 countries
5
Brief Summary
To perform a prospective, observational, international, multicentre, in vivo study to assess the performance of regular arrangement of collecting venules (RAC) for the exclusion of Helicobacter pylori (Hp) infection using white light high definition (HD) endoscopy without any kind of zoom or magnification. Gold standard will be mucosal biopsies (Sydney protocol) or urease test. Immunohistochemistry (IHC) should be performed in case of a negative histologic study for Hp in patients taking proton pump inhibitors (PPIs). Participants will perform a training test with 20 pictures of the distal part of the lesser curvature before starting the inclusion of cases. Secondary objectives are:
- To assess whether age, sex and PPIs, have an influence on the results of RAC.
- To assess the correlation of atrophic gastritis and intestinal metaplasia (confirmed in histopathological samples) and RAC.
- To assess reproducibility of RAC on real time examinations with different operators and in different countries with different Hp infection prevalence. Primary and secondary variables The primary study variable is: \- Endoscopic detection of RAC. Secondary variables will be considered:
- Sex
- Age
- PPI intake in the last two weeks
- Centre
- Country
- Hp prevalence
- Endoscopist
- Type of endoscope
- Significant findings (need of histological confirmation)
- Atrophic gastritis
- Intestinal metaplasia
- Erosive gastritis
- Benign gastric ulcer
- Gastric adenoma
- Gastric cancer
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Dec 2021
5 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 6, 2021
CompletedFirst Posted
Study publicly available on registry
September 16, 2021
CompletedStudy Start
First participant enrolled
December 1, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 30, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
September 30, 2023
CompletedMarch 1, 2023
December 1, 2022
1.6 years
September 6, 2021
February 28, 2023
Conditions
Outcome Measures
Primary Outcomes (1)
RAC performance
A total of 1000 consecutive patients with no history of Hp who come for gastroscopy will be included in the study to perform a prospective, observational, international, multicentre, in vivo study to assess the performance of regular arrangement of collecting venules (RAC). Endoscopists will perform a training test with 20 pictures of the distal part of the lesser curvature before starting the inclusion of cases. 17 different centers will participate in the study and each of them will include between 50 and 100 patients. Presence of RAC using white light high definition endoscopy without magnification determines the exclusion of Helicobacter pylori (Hp) infection. Gold standard diagnosis test for Hp infection will be histological results by mucosal biopsies (Sydney protocol) or urease test. Immunohistochemistry (IHC) should be performed in case of a negative histologic study for Hp in patients taking proton pump inhibitors (PPIs).
12 months
Secondary Outcomes (3)
Baseline characteristics
12 months
Histological correlation
12 months
Reproducibility
12 months
Study Arms (1)
RAC evaluation
Patients older than 18 years without previous history of Hp infection or eradication undergoing a gastroscopy
Interventions
This is a prospective, multicentre, international study without a control group.
Eligibility Criteria
Patients older than 18 years without previous history of Hp infection or eradication undergoing a gastroscopy in each center
You may qualify if:
- Patients older than 18 years without previous history of Hp infection or eradication undergoing a gastroscopy
You may not qualify if:
- Patients taking oral anticoagulants (acenocoumarol and new anticoagulants as dabigatran, rivaroxaban, apixaban and edoxaban), NSAIDs or with intake of antibiotics in the last 4 weeks, but aspirin at a dose of 100 mg per day will be included
- Diseases that affect the gastric mucosa and preclude the evaluation of the collecting venules pattern (portal hypertension, gastric lymphoma)
- History of previous gastric cancer or patients in surveillance for preneoplastic lesions (atrophic gastritis/IM),
- Previous gastric surgery,
- Active bleeding or presence of blood or food that would impede a complete mucosal evaluation.
- Negative to participate in the study or inability to provide signed consent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (5)
Cliniques Universitaires Saint Luc
Brussels, 1080, Belgium
München University Hospital
Munich, Bavaria, 80331, Germany
Hospital de Mérida
Mérida, Badajoz, 06800, Spain
Hospital de Viladecans
Viladecans, Barcelona, 08840, Spain
Hospital Clinic de Barcelona
Barcelona, 08036, Spain
Related Publications (2)
Garces-Duran R, Galdin-Ferreyra M, Delgado-Guillena PG, Cuatrecasas M, Cordova H, Garcia-Rodriguez A, Rodrigo-Calvo MT, Jimeno-Ramiro M, Araujo IK, Gines A, Llach J, Fernandez-Esparrach G. Diagnosis of Helicobacter pylori Infection by the Arrangement of Collecting Venules Using White Light Endoscopy: Evaluation of Interobserver Agreement. Dig Dis. 2022;40(3):376-384. doi: 10.1159/000518100. Epub 2021 Jun 30.
PMID: 34348294BACKGROUNDGarces-Duran R, Garcia-Rodriguez A, Cordova H, Cuatrecasas M, Gines A, Gonzalez-Suarez B, Araujo I, Llach J, Fernandez-Esparrach G. Association between a regular arrangement of collecting venules and absence of Helicobacter pylori infection in a European population. Gastrointest Endosc. 2019 Sep;90(3):461-466. doi: 10.1016/j.gie.2019.05.027. Epub 2019 May 17.
PMID: 31108089BACKGROUND
Study Officials
- PRINCIPAL INVESTIGATOR
Gloria Fernandez-Esparrach, PhD
Hospital Clinic of Barcelona
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 6, 2021
First Posted
September 16, 2021
Study Start
December 1, 2021
Primary Completion
June 30, 2023
Study Completion
September 30, 2023
Last Updated
March 1, 2023
Record last verified: 2022-12